Increase of serum TIMP-1 and MMP-9 expressions in COPD patients was correlated with symptoms and scores of quality of life, and the expressions were also correlated with short-term treatment reactivity. This evidence concerns the gene TIMP1 and chronic obstructive pulmonary disease.